Search for: "Gilead Sciences Limited"
Results 61 - 80
of 84
Sorted by Relevance
|
Sort by Date
9 Apr 2009, 2:12 pm
Opinion below (5th Circuit) Petition for certiorari Brief in opposition Petitioner's reply brief Brief amicus curiae of former federal and state prosecutors (in support of petitioner) Docket: 08-1021 Title: Gilead Sciences, Inc., et al., v. [read post]
22 Oct 2010, 5:39 pm
" In re Gilead Sciences Securities Litig. (9th Cir. 2008).Misrepresentation involves the logically difficult task of proving a negative. [read post]
20 May 2009, 5:18 am
’ (Patent Docs) Atripla/Truvada (Efavirenz, Emtricitabine, Tenofovir) – US: Gilead Sciences files second patent infringement lawsuit against Teva Pharmaceuticals over Emtricitabine, a component of Truvada and Atripla (SmartBrief) (The IP Factor) (GenericsWeb) Champix (Varenicline) – India: Pfizer responds to Dr Reddy’s post-grant opposition to Champix filed at Mumbai Patent Office (GenericsWeb) (Spicy IP) Corpril (Ramipril) –… [read post]
23 Jun 2020, 11:30 am
Just this spring, Gilead Sciences, Inc., of Foster City, Ca., bought a firm backed directly and indirectly by CIRM with $45 million. [read post]
30 Aug 2010, 1:12 pm
What we have, according to Osborn, is "the government's de facto policy of limited rulemaking and broad enforcement. [read post]
5 Mar 2015, 6:00 am
Gilead Sciences, Inc. v. [read post]
16 Mar 2011, 3:50 am
Abbott: Federal Circuit struggles to articulate a coherent standard for compliance with the Lilly written description requirement (Holman’s Biotech IP Blog) Lexapro (Escitalopram) – US: CAFC affirms obviousness of Infosint’s patent claims (IPBiz) Lotronex (Alosetron) – US: Prometheus files patent infringement suit against Roxane in response to Para IV challenge (Patent Docs) Pravastatine – Belgium/France: Post-expiry saisie-contrefaçon: Belgium and France… [read post]
30 Aug 2018, 6:18 am
Gilead Sciences, Inc., (discussion by C&M attorneys here), the panel held that Escobar’s two conditions must be satisfied to give rise to an implied-certification claim. [read post]
4 Aug 2022, 7:54 pm
Most of these cases have settled out of court (see, for example, Actelion Pharmaceuticals, 2018; Astellas Pharma and Amgen, 2019; Gilead Sciences, 2020). [read post]
7 Feb 2013, 9:00 am
The SEV calls for a precautionary, science-based approach to decision-making. [read post]
4 Apr 2012, 4:20 am
[Link] Gilead Sciences is searching for patent litigation counsel with a BS in life sciences and 5-8 years of experience to work at their Foster City, CA office. [read post]
27 Feb 2024, 7:08 pm
The first multiple PTE case up-to-bat concerns Gilead Sciences Inc. [read post]
28 Jan 2021, 6:09 pm
Among the claims by the limited partner was that the general partner of the limited partnership, the LLC manager, breached fiduciary duties by failing to disclose that the general partner was the only investor in the fund other than the suing limited partner, and related omissions or misrepresentations. [read post]
19 Jan 2022, 12:19 pm
Gilead Sciences, Inc., C.A. [read post]
17 May 2021, 1:03 pm
However, this standard is not without limitations. [read post]
8 Jan 2016, 5:26 am
’ In re Gilead Sciences Securities Litigation, 536 F.3d 1049 (U.S. [read post]
17 Sep 2018, 9:30 am
Brown, Zaha Hassan, Gilead Sher and Joyce Karam. [read post]
9 Mar 2020, 1:21 pm
Explanation of how contracts can limit doctors from using the drug of choice for patients: specialty pharmacy delivers drug to practice despite what they have chosen for inventory. [read post]
2 Aug 2008, 12:54 am
– Technological Innovation and Intellectual Property), IP and start-ups: (Technological Innovation and Intellectual Property), Innovators: Make sure your company owns the fruits of your open innovation projects: (IP Asset Maximizer Blog), It’s all about the numbers: SuperCrunchers of patent data will gain competitive advantage: (IP Asset Maximizer Blog) Events 4-9 August: Dept Science & Technology indigenous knowledge systems expo and workshop… [read post]
13 Aug 2021, 4:00 am
Rand Paul revealed his wife bought stock in Gilead Sciences, which makes an antiviral drug used to treat COVID-19, in February 2020, before it was classified as a pandemic by the World Health Organization. [read post]
